Portland Global Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,478
Closed -$220K 137
2020
Q3
$220K Hold
3,478
0.06% 117
2020
Q2
$268K Sell
3,478
-500
-13% -$38.3K 0.09% 92
2020
Q1
$297K Hold
3,978
0.12% 80
2019
Q4
$258K Hold
3,978
0.08% 104
2019
Q3
$252K Hold
3,978
0.08% 99
2019
Q2
$269K Sell
3,978
-500
-11% -$32.9K 0.09% 94
2019
Q1
$291K Hold
4,478
0.1% 85
2018
Q4
$280K Sell
4,478
-200
-4% -$14K 0.11% 83
2018
Q3
$361K Sell
4,678
-3,400
-42% -$257K 0.13% 81
2018
Q2
$572K Sell
8,078
-2,900
-26% -$205K 0.22% 60
2018
Q1
$828K Buy
10,978
+7,500
+216% +$596K 0.32% 50
2017
Q4
$249K Hold
3,478
0.09% 90
2017
Q3
$282K Hold
3,478
0.11% 84
2017
Q2
$246K Sell
3,478
-200
-5% -$13.3K 0.1% 91
2017
Q1
$250K Buy
3,678
+200
+6% +$14.1K 0.1% 92
2016
Q4
$249K Hold
3,478
0.11% 86
2016
Q3
$275K Hold
3,478
0.12% 86
2016
Q2
$290K Hold
3,478
0.13% 84
2016
Q1
$319K Hold
3,478
0.15% 76
2015
Q4
$352K Sell
3,478
-15
-0.4% -$1.56K 0.19% 73
2015
Q3
$343K Hold
3,493
0.2% 74
2015
Q2
$409K Buy
3,493
+168
+5% +$18.4K 0.21% 69
2015
Q1
$326K Hold
3,325
0.17% 82
2014
Q4
$313K Sell
3,325
-29
-0.9% -$3K 0.16% 84
2014
Q3
$357K Hold
3,354
0.19% 81
2014
Q2
$278K Sell
3,354
-13
-0.4% -$1.01K 0.14% 98
2014
Q1
$239K Buy
+3,367
New +$264K 0.14% 97

Other funds holding GILD

Portland Global Advisors's GILD Position: Q4 2020 in Review

Portland Global Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,478 shares — an estimated $220K sold.

Portland Global Advisors first reported a position in GILD in Q1 2014 and held it in 27 quarters. The position peaked at $828K in Q1 2018. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Portland Global Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Portland Global Advisors sold 3,478 Gilead Sciences shares in Q4 2020, an estimated $220K.
  • Portland Global Advisors first reported a position in Gilead Sciences in Q1 2014 and held it in 27 quarters.
  • Portland Global Advisors's Gilead Sciences position peaked at $828K in Q1 2018.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Portland Global Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.